Company Filing History:
Years Active: 1987
Title: Innovations by Inventor Stephan Dvorsky
Introduction
Stephan Dvorsky is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. His innovative approach has led to the creation of a unique coronary therapeutic agent.
Latest Patents
Dvorsky holds a patent for a coronary therapeutic agent in the form of soft gelatin capsules. This invention addresses previous challenges related to capsule size and the low concentration of the active substance, nifedipine. By utilizing PVP and dissolving nifedipine in THFP, Dvorsky's invention allows for a capsule weight of only 162 mg, thus improving the efficacy and usability of the medication.
Career Highlights
Stephan Dvorsky is associated with Siegfried Aktiengesellschaft, a company known for its commitment to pharmaceutical innovation. His work has not only advanced the field but has also contributed to the company's reputation as a leader in therapeutic solutions.
Collaborations
Dvorsky has collaborated with esteemed colleagues such as Franz Radivojevich and Hans Joss. Their combined expertise has fostered an environment of innovation and has led to the successful development of new pharmaceutical products.
Conclusion
Stephan Dvorsky's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to influence the industry positively.